Budget Amount *help |
¥16,770,000 (Direct Cost: ¥12,900,000、Indirect Cost: ¥3,870,000)
Fiscal Year 2017: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2016: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2015: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
|
Outline of Final Research Achievements |
Molecular mechanisms that control the enzymatic function of SETDB1, an enzyme that specifically methylates histone H3K9, were analyzed by a multiple approach. (1) We demonstrated that mono-ubiquitination modification of SETDB1 regulates gene expression via H3K9me3 activity. In addition, TRIM28, a chromatin regulator, was identified as a factor related to its regulatory mechanism. (2) SETDB1 in the nucleus showed stable expression by proteasome inhibitor and nuclear export inhibitor, and ligase X was found as a candidate factor related to it. (3) In order to conduct X-ray crystal structure analysis of SETDB1-MCAF1, we performed protein purification and its crystallization. The novel finding of SETDB1 clarified in this research leads to the development of new cancer therapeutic drug targeting SETDB1.
|